Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy vs No Chemotherapy in Resected Gallbladder Cancer
NCT02778308Completed
- Sponsor
- Govind Ballabh Pant Hospital
- Start
- Jan 2012
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of gemcitabine and cisplatin in gallbladder cancer (2 arms), sponsored by Govind Ballabh Pant Hospital. Primary endpoint: Disease Free Survival at 100 months. Started Jan 2012; status: completed.
02
Drugs
gemcitabinecisplatin
03
Conditions
gallbladder cancer
Beyond the preview
Go deeper on NCT02778308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02778308.